Phase 3 Neurological Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
Sensation DisordersLeber Congenital AmaurosisRetinal Disease+7 more
Laboratoires Thea32 enrolled14 locationsNCT06891443
Recruiting
Phase 3
PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury
Intensive Care MedicineAcute brain injuryQuality of Life+4 more
The George Institute3,300 enrolled9 locationsNCT06819592
Recruiting
Phase 3Phase 4
Effect of prophylactic azithromycin on chest infections in children with neurological and neuromuscular impairment
Neurological impairment
Menzies School of Health Research94 enrolled2 locationsACTRN12621001486819
Recruiting
Phase 3
Joint UK and Australia multicentre, randomised, double blind, placebo controlled pragmatic trial comparing 52 weeks of azithromycin to placebo in children with neurological impairment at risk of lower respiratory tract infection (the PARROT trial).
Neurological impairment
University of Liverpool500 enrolled4 locationsACTRN12619001597189
Withdrawn
Phase 3
Training therapists to coach individuals with a neurological condition to use the SMART Arm.
StrokeNeurological conditions
James Cook University50 enrolled1 locationACTRN12616000447459